AFJK Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

50.020

Open

50.020

VWAP

48.98

Vol

3.15K

Mkt Cap

304.25M

Low

48.460

Amount

154.38K

EV/EBITDA(TTM)

--

Total Shares

6.12M

EV

294.52M

EV/OCF(TTM)

--

P/S(TTM)

--

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.

Show More

Events Timeline

(ET)

2026-01-21

14:30:00

Aimei Health Technology Co Ltd Trading Halted

2026-01-16 (ET)

2026-01-16

09:50:00

Aimei Health Technology Co Ltd Trading Halted Due to Volatility

2025-12-31 (ET)

2025-12-31

09:40:00

Aimei Health Technology Co Ltd Trading Halted Due to Volatility

2025-12-30 (ET)

2025-12-30

12:20:00

Aimei Health Technology Co Ltd Trading Halted Due to Volatility

2025-12-24 (ET)

2025-12-24

09:40:00

Aimei Health Technology Co Ltd Trading Halted Due to Volatility

News

Benzinga

WhiteFiber Inc (WYFI) Announces $200 Million Convertible Notes Offering, Shares Drop 5.5%

Benzinga

mF International Files Mixed Shelf, Shares Drop 4.6%

Benzinga

Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%

Benzinga

Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%

Benzinga

Baidu Inc Proposes Spinoff of Kunlunxin H Shares, Stock Rises 12.3%

Benzinga

2025-12-31Benzinga

FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%

Valuation Metrics

The current forward P/E ratio for Aimei Health Technology Co Ltd (AFJK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Aimei Health Technology Co Ltd 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.11

Current PS

0.00

Overvalued PS

1.23

Undervalued PS

-1.01

Financials

AI Analysis

Annual

Quarterly

Whales Holding AFJK

W. R. Berkley Corporation

Trading Trends

People Also Watch

Frequently Asked Questions

What is Aimei Health Technology Co Ltd (AFJK) stock price today?

The current price of AFJK is 48.46 USD — it has increased 1.3 % in the last trading day.

What is Aimei Health Technology Co Ltd (AFJK)'s business?

Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.

What is the price predicton of AFJK Stock?

Wall Street analysts forecast AFJK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFJK is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aimei Health Technology Co Ltd (AFJK)'s revenue for the last quarter?

Aimei Health Technology Co Ltd revenue for the last quarter amounts to -130.15K USD, decreased -34.93 % YoY.

What is Aimei Health Technology Co Ltd (AFJK)'s earnings per share (EPS) for the last quarter?

Aimei Health Technology Co Ltd. EPS for the last quarter amounts to -96109.00 USD, decreased % YoY.

How many employees does Aimei Health Technology Co Ltd (AFJK). have?

Aimei Health Technology Co Ltd (AFJK) has 0 emplpoyees as of February 07 2026.

What is Aimei Health Technology Co Ltd (AFJK) market cap?

Today AFJK has the market capitalization of 304.25M USD.